Literature DB >> 31949849

Changes in spontaneous thrombolytic activity during progression of atherosclerosis in Apo-/- and LDLR-/- double knockout mice.

Takumi Sato1, Manami Yoshimura1, Tomohide Sanda1, Kanae Hyodo1, Junichiro Yamamoto1, Hiromitu Ishii1,2, Tsutomu Yamashita1.   

Abstract

BACKGROUND: Atherosclerosis is characterized by a hypercoagulable state, during which both coagulation and thrombolytic factors are activated simultaneously. However, details regarding the thrombolytic pathway in this context remain unknown. Here we investigated the changes in spontaneous thrombolytic activity during atherosclerotic progression in Apo-/-LDLR-/- double-knockout mice (DKO group).
METHODS: We fed DKO mice and their controls (C57Bl6 mice) a high-fat diet for a total of 22 weeks and evaluated them at 14 and 22 weeks. The amount of atherosclerosis was estimated as the ratio of the atherosclerotic to total aortic intimal area. In addition, we used immunohistochemistry to analyze the expression of PAI-1, t-PA, and eNOS in atherosclerotic regions. To evaluate thrombolysis, we used a He-Ne laser to induce thrombosis in vessels of the cremaster muscle and then measured the thrombus volume over time.
RESULTS: The atherosclerotic area was increased and thrombolytic activity was decreased in DKO group compared with the control group. Furthermore, the plasma PAI-1 level was 3 times greater in the DKO group than in the control group. In support of these results, immunohistochemistry showed increased PAI-1 expression in the DKO group, whereas t-PA and eNOS expression was greater in the control group.
CONCLUSION: Progression of atherosclerosis led to a reduction in thrombolytic activity through decreases in t-PA and eNOS levels and an increase in PAI-1 production. These findings indicate that decreases in factors that promote spontaneous thrombolytic activity may indicate increased risk for the progression of atherosclerosis. IJCEP
Copyright © 2018.

Entities:  

Keywords:  PAI-1; Thrombolysis; atherosclerosis; eNOS; t-PA

Year:  2018        PMID: 31949849      PMCID: PMC6962993     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  40 in total

Review 1.  Malfunction of vascular control in lifestyle-related diseases: endothelial nitric oxide (NO) synthase/NO system in atherosclerosis.

Authors:  Seinosuke Kawashima
Journal:  J Pharmacol Sci       Date:  2004-12       Impact factor: 3.337

2.  The primary inhibitor of plasmin in human plasma.

Authors:  S Müllertz; I Clemmensen
Journal:  Biochem J       Date:  1976-12-01       Impact factor: 3.857

Review 3.  Stability and instability: two faces of coronary atherosclerosis. The Paul Dudley White Lecture 1995.

Authors:  M J Davies
Journal:  Circulation       Date:  1996-10-15       Impact factor: 29.690

4.  Increased expression and co-localization of ACE, angiotensin II AT(1) receptors and inducible nitric oxide synthase in atherosclerotic human coronary arteries.

Authors:  Mitsuru Ohishi; Gregory J Dusting; Paul A Fennessy; Frederick Ao Mendelsohn; Xiao C Li; Jia L Zhuo
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2010-04-30

5.  Plasminogen activator inhibitor type 1 is increased in the arterial wall of type II diabetic subjects.

Authors:  A Pandolfi; D Cetrullo; R Polishuck; M M Alberta; A Calafiore; G Pellegrini; E Vitacolonna; F Capani; A Consoli
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-08       Impact factor: 8.311

6.  Varying the ratio of dietary n-6/n-3 polyunsaturated fatty acid alters the tendency to thrombosis and progress of atherosclerosis in apoE-/- LDLR-/- double knockout mouse.

Authors:  T Yamashita; E Oda; T Sano; T Yamashita; Y Ijiru; J C Giddings; J Yamamoto
Journal:  Thromb Res       Date:  2005-02-25       Impact factor: 3.944

7.  The effect of the long term aspirin administration on the progress of atherosclerosis in apoE-/- LDLR-/- double knockout mouse.

Authors:  Y Yamamoto; T Yamashita; F Kitagawa; K Sakamoto; J C Giddings; J Yamamoto
Journal:  Thromb Res       Date:  2009-12-16       Impact factor: 3.944

Review 8.  Endothelial function: a critical determinant in atherosclerosis?

Authors:  Ulf Landmesser; Burkhard Hornig; Helmut Drexler
Journal:  Circulation       Date:  2004-06-01       Impact factor: 29.690

9.  Guidelines for Thrombolytic Therapy for Acute Stroke: a Supplement to the Guidelines for the Management of Patients with Acute Ischemic Stroke. A statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association.

Authors:  H P Adams; T G Brott; A J Furlan; C R Gomez; J Grotta; C M Helgason; T Kwiatkowski; P D Lyden; J R Marler; J Torner; W Feinberg; M Mayberg; W Thies
Journal:  Stroke       Date:  1996-09       Impact factor: 7.914

10.  Impact of gradual blood flow increase on ischaemia-reperfusion injury in the rat cremaster microcirculation model.

Authors:  Selahattin Ozmen; Suhan Ayhan; Yavuz Demir; Maria Siemionow; Kenan Atabay
Journal:  J Plast Reconstr Aesthet Surg       Date:  2007-07-16       Impact factor: 2.740

View more
  1 in total

1.  Dietary Supplementation with Selenium and Coenzyme Q10 Prevents Increase in Plasma D-Dimer While Lowering Cardiovascular Mortality in an Elderly Swedish Population.

Authors:  Urban Alehagen; Jan Aaseth; Tomas L Lindahl; Anders Larsson; Jan Alexander
Journal:  Nutrients       Date:  2021-04-17       Impact factor: 5.717

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.